➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Nostrum Labs Inc Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NOSTRUM LABS INC, and what generic and branded alternatives to NOSTRUM LABS INC drugs are available?

NOSTRUM LABS INC has thirty-three approved drugs.

Summary for Nostrum Labs Inc

US Patents:	0
Tradenames:	32
Ingredients:	30
NDAs:	33

Drugs and US Patents for Nostrum Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nostrum Labs Inc	NITROFURANTOIN	nitrofurantoin	SUSPENSION;ORAL	201355-001	Aug 14, 2013	AB	RX	No	No		Start Trial				Start Trial
Nostrum Labs Inc	CARBAMAZEPINE	carbamazepine	CAPSULE, EXTENDED RELEASE;ORAL	076697-003	May 20, 2011	AB	RX	No	No		Start Trial				Start Trial
Nostrum Labs Inc	PIROXICAM	piroxicam	CAPSULE;ORAL	074116-001	Jun 15, 1993	AB	RX	No	No		Start Trial				Start Trial
Nostrum Labs Inc	HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE	homatropine methylbromide; hydrocodone bitartrate	SYRUP;ORAL	210663-001	Jun 11, 2019		DISCN	No	No		Start Trial				Start Trial
Nostrum Labs Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	209385-002	Jul 2, 2018	AA	RX	No	No		Start Trial				Start Trial
Nostrum Labs Inc	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	enalapril maleate; hydrochlorothiazide	TABLET;ORAL	076486-001	Oct 27, 2004	AB	RX	No	No		Start Trial				Start Trial
Nostrum Labs Inc	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	enalapril maleate; hydrochlorothiazide	TABLET;ORAL	076486-002	Oct 27, 2004	AB	RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

AstraZeneca

Colorcon

Harvard Business School

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.